T cell-mediated graft-versus-leukemia reactions after allogeneic stem cell transplantationSCHETELIG, Johannes; KIANI, Alexander; SCHMITZ, Marc et al.Cancer immunology and immunotherapy. 2005, Vol 54, Num 11, pp 1043-1058, issn 0340-7004, 16 p.Article

Infections with human herpesvirus 6 variant B delay platelet engraftment after allogeneic haematopoietic stem cell transplantationRADONIC, Aleksandar; OSWALD, Olivia; THULKE, Stefanie et al.British journal of haematology. 2005, Vol 131, Num 4, pp 480-482, issn 0007-1048, 3 p.Article

Alemtuzumab depletes dendritic cells more effectively in blood than in skin: A pilot study in patients with chronic lymphocytic leukemiaAUFFERMANN-GRETZINGER, Susanne; EGER, Lars; SCHETELIG, Johannes et al.Transplantation. 2007, Vol 83, Num 9, pp 1268-1272, issn 0041-1337, 5 p.Article

Impact of allogeneic haematopoietic stem cell transplantation in patients with abnl(17p) acute myeloid leukaemiaMOHR, Brigitte; SCHETELIG, Johannes; PLATZBECKER, Uwe et al.British journal of haematology. 2013, Vol 161, Num 2, pp 237-244, issn 0007-1048, 8 p.Article

Gemtuzumab Ozogamicin as Part of Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed Acute Myeloid LeukemiaBORNHÄUSER, Martin; ILLMER, Thomas; PLATZBECKER, Uwe et al.Clinical cancer research (Print). 2008, Vol 14, Num 17, pp 5585-5593, issn 1078-0432, 9 p.Article

Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infectionMORGNER, Andrea; MIEHLKE, Stephan; EHNINGER, Gerhard et al.Journal of clinical oncology. 2001, Vol 19, Num 7, pp 2041-2048, issn 0732-183XArticle

Reconstitution of 6-Sulfo LacNAc Dendritic Cells After Allogeneic Stem-Cell TransplantationMAGER, Konrad; WEHNER, Rebekka; SCHETELIG, Johannes et al.Transplantation. 2012, Vol 93, Num 12, pp 1270-1275, issn 0041-1337, 6 p.Article

Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host diseaseSCHETELIG, Johannes; KRÖGER, Nicolaus; ZANDER, Axel R et al.Haematologica (Roma). 2002, Vol 87, Num 3, pp 299-305, issn 0390-6078Article

Early autologous stem cell transplantation for chronic lymphocytic leukemia: long-term follow-up of the German CLL Study Group CLL3 trialDREGER, Peter; DÖHNER, Hartmut; DÜHRSEN, Ulrich et al.Blood. 2012, Vol 119, Num 21, pp 4851-4859, issn 0006-4971, 9 p.Article

Monitoring of donor chimerism in sorted CD34⁺ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantationBORNHÄUSER, Martin; OELSCHLAEGEL, Uta; THEUSER, Catrin et al.Haematologica (Roma). 2009, Vol 94, Num 11, pp 1613-1617, issn 0390-6078, 5 p.Article

High-Dose Cytarabine Consolidation With or Without Additional Amsacrine and Mitoxantrone in Acute Myeloid Leukemia: Results of the Prospective Randomized AML2003 TrialSCHAICH, Markus; PARMENTIER, Stefani; EINSELE, Hermann et al.Journal of clinical oncology. 2013, Vol 31, Num 17, pp 2094-2102, issn 0732-183X, 9 p.Article

Assessment of dysplastic hematopoiesis: lessons from healthy bone marrow donorsPARMENTIER, Stefani; SCHETELIG, Johannes; EHNINGER, Gerhard et al.Haematologica (Roma). 2012, Vol 97, Num 5, pp 723-730, issn 0390-6078, 8 p.Article

Allogeneic Hematopoietic Stem-Cell Transplantation for Chronic Lymphocytic Leukemia With 17p Deletion : A Retrospective European Group for Blood and Marrow Transplantation AnalysisSCHETELIG, Johannes; VAN BIEZEN, Anja; GANSER, Arnold et al.Journal of clinical oncology. 2008, Vol 26, Num 31, pp 5094-5100, issn 0732-183X, 7 p.Article

Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia : a retrospective analysisBORNHÄUSER, Martin; KIEHL, Michael; THEUSER, Catrin et al.British journal of haematology. 2001, Vol 115, Num 1, pp 119-124, issn 0007-1048Article

Clonal Evolution Including Partial Loss of Human Leukocyte Antigen Genes Favoring Extramedullary Acute Myeloid Leukemia Relapse After Matched Related Allogeneic Hematopoietic Stem Cell TransplantationSTÖLZEL, Friedrich; HACKMANN, Karl; ILLMER, Thomas et al.Transplantation. 2012, Vol 93, Num 7, pp 744-749, issn 0041-1337, 6 p.Article

Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and ―5/5q―MIDDEKE, Jan M; BEELEN, Dietrich; SCHWERDTFEGER, Rainer et al.Blood. 2012, Vol 120, Num 12, pp 2521-2528, issn 0006-4971, 8 p.Article

MRI-Based Liver Iron Content Predicts for Nonrelapse Mortality in MDS and AML Patients Undergoing Allogeneic Stem Cell TransplantationWERMKE, Martin; SCHMIDT, Anne; SCHETELIG, Johannes et al.Clinical cancer research (Print). 2012, Vol 18, Num 23, pp 6460-6468, issn 1078-0432, 9 p.Article

¹⁸⁸Re anti-CD66 radioimmunotherapy combined with reduced-intensity conditioning and in-vivo T cell depletion in elderly patients undergoing allogeneic haematopoietic cell transplantationLAUTER, Anett; STRUMPF, Annette; KOTZERKE, Jorg et al.British journal of haematology. 2010, Vol 148, Num 6, pp 910-917, issn 0007-1048, 8 p.Article

Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantationSCHETELIG, Johannes; FETSCHER, Sebastian; KIMBY, Eva et al.Haematologica (Roma). 2003, Vol 88, Num 11, pp 1272-1278, issn 0390-6078, 7 p.Article

Cytarabine Dose of 36 g/m² Compared With 12 g/m² Within First Consolidation in Acute Myeloid Leukemia: Results of Patients Enrolled Onto the Prospective Randomized AML96 StudySCHAICH, Markus; RÖLLIG, Christoph; SCHAFER-ECKART, Kerstin et al.Journal of clinical oncology. 2011, Vol 29, Num 19, pp 2696-2702, issn 0732-183X, 7 p.Article

Prophylactic transfer of BCR-ABL―, PR1-, and WT1-reactive donor T cells after T cell―depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemiaBORNHÄUSER, Martin; THIEDE, Christian; WERMKE, Martin et al.Blood. 2011, Vol 117, Num 26, pp 7174-7184, issn 0006-4971, 11 p.Article

Matched Unrelated or Matched Sibling Donors Result in Comparable Survival After Allogeneic Stem-Cell Transplantation in Elderly Patients With Acute Myeloid Leukemia : A Report From the Cooperative German Transplant Study GroupSCHETELIG, Johannes; BORNHDUSER, Martin; WIEDEMANN, Barbel et al.Journal of clinical oncology. 2008, Vol 26, Num 32, pp 5183-5191, issn 0732-183X, 9 p.Article

After major ABO-mismatched allogeneic hematopoietic progenitor cell transplantation, erythroid engraftment occurs later in patients with donor blood group A than donor blood group BSCHETELIG, Johannes; BREITSCHAFT, Astrid; KRÖGER, Nicolaus et al.Transfusion (Philadelphia, PA). 2005, Vol 45, Num 5, pp 779-787, issn 0041-1132, 9 p.Article

A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomasENBLAD, Gunilla; HAGBERG, Hans; ERLANSON, Martin et al.Blood. 2004, Vol 103, Num 8, pp 2920-2924, issn 0006-4971, 5 p.Article

Kinetics of stem cell engraftment and clearance of leukaemia cells after allogeneic stem cell transplantation with reduced intensity conditioning in chronic myeloid leukaemiaKREUZER, Karl-Anton; SCHMIDT, Christian Andreas; SCHETELIG, Johannes et al.European journal of haematology. 2002, Vol 69, Num 1, pp 7-10, issn 0902-4441Article